Bravecto Dog Spot-On Very Small (2-4.5kg)

Save $14.40
Bravecto8713184195784

Price:
Sale price$33.60 Regular price$48.00
 
Contains
Contains
112.5 mg fluralaner

Description

Bravecto Spot-On is an innovative medication for dogs with fleas and ticks. In dogs, it efficiently treats flea and tick infestations and controls potential infestations. Within 8 hours, the topical solution begins to kill fleas and provides continuous protection for 6 months against fleas and flea infestations. It has a systemic tick-acaricide effect and offers 6 months of sustained killing activity against paralysis ticks. The topical remedy works for 12 full weeks against Brown Dog ticks. Bravecto spot-on can be used as part of a flea-allergy dermatitis prevention care plan. For puppies over 8 weeks of age and at least 2 kg, it is safe to use. The topical treatment of Bravecto is appropriate for use in raising, pregnant, and lactating dogs.
How does it work?
As its active ingredient, Bravecto Spot-On contains Fluralaner. The ingredient is highly active against ticks and fleas. It is very successful against the target parasites. By acting belligerently on ligand-gated chloride channels (GABA-receptor and glutamate-receptor), Fluralaner is effective in inhibiting parts of the nervous system of the parasite. Thus, fleas and ticks are destroyed. Before they lay eggs, Bravecto kills the newly emerging fleas. It splits the life cycle of fleas and controls further infestations. The spot-on is simple to use and provides a large safety range.
Rest easier with 6 months protection from fleas and paralysis ticks in one Spot-on
Our TWIST'N'USE tube makes it quick and easy to apply
Give your dog nose-to-toes protection wherever they go

KEY BENEFITS:
  • Eliminates fleas within 8 hours of administration
  • Effectively kills newly emerged fleas
  • Provides persistent flea protection up to 24 weeks
  • Controls flea population in the surrounding areas
  • Provides long lasting efficacy
  • Breaks flea life cycle and further controls flea infestations
  • Safe for all breeds of dogs
Beat fleas reliably 6 months at a time
Delivering fast protection that lasts. A single treatment with Bravecto Spot-on gives your dog effective cover for a full 6 months and controls Flea Allergy Dermatitis (FAD).
Protect against the threat of paralysis ticks for 6 months
Give your dog protection from the single most dangerous tick for canines in Australia. Bravecto Spot-on for Dogs is 100% effective against paralysis ticks within the critical 72 hour period following tick attachment for both new and pre-existing tick infestations.
Enjoy simple and convenient application
Our TWIST'N'USE tube makes it easy and hassle-free to apply Bravecto Spot-on, without fuss for you or your dog. It also provides a great alternative for dogs that don't like tablets, or where longer lasting protection is required.
Bravecto can be used on puppies from 8 weeks of age, weighing at least 2 kg
Enjoy peace of mind knowing that once your puppy is old enough to enjoy an active outdoor lifestyle, they'll be protected from the risks of fleas and paralysis ticks.
Extensively tested and continually monitored
With comprehensive clinical research, Bravecto has been proven safe for use in breeding, pregnant and lactating dogs as well as puppies over 8 weeks of age weighing at least 2 kg.
Global safety monitoring of Bravecto use continues to provide additional compelling evidence of the safety of the product.
CLINICAL PHARMACOLOGY
Peak fluralaner concentrations are achieved between 7 and 42 days following topical administration and the elimination half-life ranges between 14 and 29 days. The bioavailability of fluralaner following oral and topical administration is approximately 25 %.
PHARMACODYNAMIC PROPERTIES
Fluralaner is an acaricide and insecticide. It is efficacious against ticks, fleas and mites.
Fluralaner is for systemic use and belongs to the class of isoxazoline-substituted benzamide derivatives.
Fluralaner is an inhibitor of parts of the arthropod nervous system. The mode of action of fluralaner is the antagonism of the ligand-gated chloride channels (gamma-aminobutyric acid (GABA)-receptor and glutamate-receptor).

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

You may also like

Recently viewed